Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes

European Journal of Clinical Investigation

Volumn 29, Issue 8, 1999, Pages 663-671

  Dullaart, R P F ^a   Riemens, S C ^a   Scheek, L M ^b,c   Van Tol, A ^b,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Cholesterol esterification; Cholesteryl ester transfer; Free fatty acids; High density lipoproteins; Insulin; Triglycerides; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL ESTER; INSULIN; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CLINICAL ARTICLE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEINS B; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; DIABETES MELLITUS, TYPE 2; GLYCOPROTEINS; HUMANS; INSULIN; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 0032810963     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00521.x     Document Type: Article

References (56)

1. 1 Tall AR. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest 1990; 86: 379-84.
2. 2 Barter P. High density lipoproteins and reverse cholesterol transport. Curr Opin Lipidol 1993; 4: 210-7.
3. 3 Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36: 211-28.
4. 4 Bruce C, Tall AR. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr Opin Lipidol 1995; 6: 306-11.
5. 5 Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984; 25: 1017-58.
6. 6 Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-beta-migrating high density lipoprotein. Biochemistry 1988; 27: 25-9.
7. 7 Von Eckardstein A, Huang Y, Assmann G. Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr Opinion Lipidol 1994; 5: 404-16.
8. 8 Bamberger M, Glick JM, Rothblat GH. Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells. J Lipid Res 1983; 24: 869-76.
9. 9 Varban ML, Rinninger F, Wang N, Fairchild-Huntress V, Dunmore JH, Fang Q, et al. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 1998; 95: 4619-24.
10. 10 Dullaart RPF, Groener JEM, Erkelens DW. Cholesteryl ester transfer between lipoproteins. Diab Nutr Metab 1991; 14: 329-43.
11. 11 Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34: 1255-74.
12. 12 Stout RW. Insulin and atheroma. 20-yr perspective. Diabetes Care 1990; 13: 631-54.
13. 13 Jarrett RJ. Why is insulin not a risk factor for coronary heart disease? Diabetologia 1994; 37: 945-7.
14. 14 Reaven GM, Laws A. Insulin resistance, compensatory hyperinsulinaemia and coronary heart disease. Diabetologia 1994; 37: 948-52.
15. 15 Fontbonne A. Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia 1994; 37: 953-5.
16. 16 Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952-7.
17. 17 Brazg RL, Bierman EL. Insulin excess counteracts the effects of HDL on intracellular sterol accumulation in cultured human skin fibroblasts. Diabetologia 1993; 36: 942-7.
18. 18 Wybranska I, Baczynska E, Cialowicz U, Polus A, Dembinnska-Kiec A. Influence of insulin on cholesterol removal from macrophages and cholesterol ester uptake by HepG2 cells. Eur J Clin Invest 1996; 26: 1004-10.
19. 19 Baynes C, Henderson AD, Richmond W, Johnston DG, Elkeles RS. The response of hepatic lipase and serum lipoproteins to acute hyperinsulinaemia in type 2 diabetes. Eur J Clin Invest 1992; 22: 341-6.
20. 20 Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991; 88: 2059-66.
21. 21 Murakami T, Michelagnoli S, Longhi R, Gianfranceschi G, Pazzucconi F, Calabresi L, et al. Triglycerides are major determinants of cholesterol esterification/transter and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol 1995; 15: 1819-28.
22. 22 Riemens SC, Van Tol A, Sluiter WJ, Dullaart RPF. Elevated plasma cholesteryl ester transfer in NIDDM. relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis 1998; 140: 71-9.
23. 23 Yki-Järvinen H, Taskinen MR, Koivisto VA, Nikkilä EA. Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man. Diabetologia 1984; 27: 364-9.
24. 24 Ligtenberg JJM, Van Tol A, Van Haeften TW, Sluiter WJ, Reitsma WD, Dullaart RPF. Impaired suppression of plasma free fatty acids and triglycerides by acute hyperglycaemia-induced hyperinsulinaemia and alterations in high density lipoproteins in essential hypertension. J Intern Med 1996; 240: 233-42.
25. 25 Van Tol A, Ligtenberg JJM, Riemens SC, Van Haeften TW, Reitsma WD, Dullaart RPF. Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men. Scand J Clin Lab Invest 1997; 57: 147-58.
26. 26 Bhatnagar D, Durrington PN, Kumar S, Mackness MI, Boulton AJM. Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to very low density and low density lipoproteins in patients with non-insulin-dependent diabetes mellitus. Diabetic Medicine 1996; 13: 139-44.
27. 27 Lottenberg SA, Lottenberg AMP, Nunes VS, McPherson R, Quintao ECR. Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in Type II diabetics and normal controls. Atherosclerosis 1996; 127: 81-90.
28. 28 Ahnadi CE, Masmoudi T, Berthezène F, Ponsin G. Decreased ability of high density lipoproteins to transfer cholesterol esters in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1993; 23: 459-65.
29. 29 Bagdade JD, Lane JT, Subbaiah PV, Otto ME, Ritter MC. Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus. Atherosclerosis 1993; 104: 69-77.
30. 30 Sutherland WH, Walker RJ, Lewis-Barned NJ, Pratt H, Tillman HC. Plasma cholesteryl ester transfer in patients with non-insulin dependent diabetes mellitus. Clin Chim Acta 1994; 231: 29-38.
31. 31 National Diabetes Data group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-57.
32. 32 Dullaart RPF, Hoogenberg K, Dikkeschei LD, Van Tol A. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb 1994; 14: 1581-5.
33. 33 Mero N, Van Tol A, Scheek LM, Van Gent T, Labeur C, Rosseneu M, et al. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities. J Lipid Res 1998; 39: 1493-502.
34. 34 Jones DY, Judd JT, Taylor PR, Campbell WS, Nair PP. Menstrual cycle effect on plasma lipids. Metabolism 1988; 37: 1-2.
35. 35 Channon KM, Clegg RJ, Bhatnagar D, Ishola M, Arrol S, Durrington PN. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer. Atherosclerosis 1990; 80: 217-26
36. 36 Steyer E, Kostner GM. Activation of lecithin-cholesterol acyltransferase by apolipoprotein D. comparison of proteoliposomes containing apolipoprotein D, AI or CL Biochim Biophys Acta 1984; 958: 484-91.
37. 37 Demacker PN, Hijmans AG, Vos-Janssen HE, Van't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin Chem 1980; 26: 1775-9.
38. 38 Dullaart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188-94.
39. 39 Tall AR, Granot E, Brocia R, Tabas I, Hesler C, Williams K, et al. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest 1987; 79: 1217-25.
40. 40 Tollefson JH, Ravnik S, Albers JJ. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res 1988; 29: 1593-602.
41. 41 Sammett D, Tall AR. Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis. J Biol Chem 1985; 260: 6687-97.
42. 42 Lagrost L, Florentin E, Guyard-Dangremont V, Athias A, Gandjini H, Lallemant C, et al. Evidence for nonesterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma. Arterioscler Thromb Vasc Biol 1995; 15: 1388-96.
43. 43 Riemens SC, Van Tol A, Sluiter WJ, Dullaart RPF. Plasma phospholipid transfer protein activity is related to insulin resistance impaired acute lowering by insulin in obese Type II diabetic patients. Diabetologia 1998; 41: 929-34.
44. 44 Arii K, Suehiro T, Yamamoto M, Ito H, Hashimoto K. Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid. Metabolism 1997; 46: 1166-70.
45. 45 Barter PJ. Enzymes involved in lipid and lipoprotein metabolism. Curr Opin Lipidol 1990; 1: 518-23.
46. 46 Van Tol A. CETP-catalysed transfer of cholesterylesters from HDL to apoB-containing lipoproteins in plasma from diabetic patients. Eur J Clin Invest 1993; 23; 856 (letter).
47. 47 Elchebly M, Porokhov B, Pulcini T, Berthezène F, Ponsin G. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM). Atherosclerosis 1996; 123: 93-101.
48. 48 Fielding CJ, Fielding PE. Regulation of human plasma lecithin: cholesterol acyltransferase activity by lipoprotein acceptor cholesteryl ester content. J Biol Chem 1981; 256: 2102-4.
49. 49 Schernthaner G, Kostner GM, Dieplinger H, Prager R, Mühlhauser I. Apolipoproteins (A-, A-II, B), Lp (a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus. Atherosclerosis 1983; 49: 277-93.
50. 50 Fielding CJ, Reaven GM, Liu G, Fielding PE. Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci USA 1984; 81: 2512-6.
51. 51 Manzato E, Zambon A, Lapolla A, Zambon S, Braghetto L, Crepaldi G, et al. Lipoprotein abnormalities in well-treated Type II diabetic patients. Diabetes Care 1993; 16: 469-75.
52. 52 Chen YD, Swami S, Skowronski R, Coulston A, Reaven GM. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 76: 172-7.
53. 53 Guérin M, Dolphin PJ, Chapman MJ. Preferential cholesteryl ester acceptors among the LDL subspecies of subjects with familial hypercholesterolemia. Arterioscler Thromb 1994; 14: 679-85.
54. 54 Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996; 97: 2917-23.
55. 55 Tall AR. Plasma lipid transfer proteins. J Lipid Res 1986; 27: 361-7.
56. 56 Fielding CJ, Havel RJ. Cholesteryl ester transfer protein: Friend or foe? J Clin Invest 1996; 97: 2687-8.